Correction to: British Journal of Cancer (2014) 110, 510–519. doi:https://doi.org/10.1038/bjc.2013.731; published online 10 December 2013
The name of the fourth author was omitted. The author is Lyn Schedlich, and all the author names and affiliations are shown correctly above.
This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License.
Change history
20 March 2018
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
Author information
Authors and Affiliations
Additional information
The online version of the original article can be found at https://doi.org/10.1038/bjc.2013.731
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/
About this article
Cite this article
Linton, A., Cheng, Y., Griggs, K. et al. Erratum: An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma. Br J Cancer 118, e13 (2018). https://doi.org/10.1038/bjc.2018.3
Published:
Issue Date:
DOI: https://doi.org/10.1038/bjc.2018.3
This article is cited by
-
Development of an interfering peptide M1-20 with potent anti-cancer effects by targeting FOXM1
Cell Death & Disease (2023)